Part funded by the European Regional Development Fund through the Welsh Government’s Sêr Cymru scheme, the Medicines Discovery Institute aims to translate fundamental discoveries in disease processes and the identification of molecular targets into new drugs.
According to the NHS, currently almost half of all adults in the UK take prescription drugs either as a prevention or treatment. We provide a centre of excellence, translating research expertise into new treatments for use in the healthcare environment.
Our main research aim is to deliver modern drug discoveries to improve established treatments, either with new approaches to old targets or by developing innovative approaches through new targets.
Bringing together world-leading scientists to produce and identify new drug candidates, we are a unique conduit for collaboration with the pharmaceutical industry. Our research covers modern drug discovery across the spectrum of oncology, immunity, neuroscience and central nervous system diseases.
We foster vital links between our researchers and the pharmaceutical industry, allowing us to translate our research into real products that can improve the lives of people all over the world, whilst putting Wales at the forefront of medical innovation.